Peptide therapy claims on TikTok: what the science actually supports

What did @hawthorneresearch1 actually say?

The creator describes peptides as "a chain of amino acids" that act like "keys" fitting into receptor "locks." They then focus on BPC-157, calling it "the gut healer" and a "naturally occurring peptide that's found in your stomach" whose "main job is protecting the lining of the stomach." They also describe the common practice of injecting it near injuries like tennis elbow to "speed the recovery."

The video is short and uses accessible analogies. The creator identifies as board-certified but does not specify their specialty. Most of the claims are mechanistic or descriptive, which makes them easier to evaluate against existing research. No dosing advice is given, and no disease cure is claimed outright, which keeps this video on the safer side of the peptide content spectrum on TikTok.

Does the science back this up?

Partially, but there are important gaps. The animal data on BPC-157 is genuinely interesting. The human clinical data is almost nonexistent, and that distinction matters a lot.

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. The "naturally occurring" framing is accurate in a narrow sense: the parent protein exists in gastric juice, but BPC-157 itself is a lab-synthesized fragment, not something your body produces and circulates freely. Studies in rodents have shown it promotes angiogenesis, accelerates tendon-to-bone healing, and demonstrates gastroprotective effects (Sikiric et al., 2018, Current Pharmaceutical Design). A 2021 review in Biomedicines (Gwyer et al.) confirmed promising musculoskeletal repair signals in animal models. But as of 2024, there are no published randomized controlled trials in humans. The FDA has not approved BPC-157 for any indication, and it is currently banned from use in compounded medications sold through telehealth under the FDA's 2023 guidance.

What did they get wrong (or right)?

They got the basic biochemistry right, and they got the clinical picture incomplete.

The receptor "key and lock" analogy is a reasonable simplification, though peptides interact with receptors in more varied ways than a single metaphor captures. The claim that BPC-157 is "found in your stomach" needs a qualifier: it is derived from a gastric protein, but the peptide fragment itself is not endogenously circulating in a therapeutically meaningful concentration. Saying it is "naturally occurring" without that nuance risks implying it is something your body already makes in usable form, which is misleading framing commonly used to make synthetic compounds sound safer than they are.

The injury injection claim, "hoping that it's going to speed the recovery," is appropriately hedged with the word "hoping." That is honest. The mechanism they describe, rapid cell regeneration, is supported in animal tissue studies (Chang et al., 2011, Journal of Applied Physiology), but translating that to subcutaneous injection near a human tendon is a significant leap the video does not adequately flag.

What should you actually know?

BPC-157 is not approved for human use by the FDA, and that is not a technicality you should ignore.

The FDA in 2023 placed BPC-157 on its list of substances that cannot be compounded by outsourcing facilities, citing insufficient evidence of safety and effectiveness in humans. That does not mean the animal research is fake or uninteresting. It means the jump from rat tendon studies to human injection protocols has not been validated by the kind of controlled evidence that would normally justify clinical use. People are injecting an unvalidated compound near tendons based largely on preclinical data and anecdote, and they are often doing so without medical supervision.

If you are curious about peptide therapies for injury recovery, the honest answer right now is that the science is early-stage and the regulatory environment is shifting fast. That is a reason for careful attention, not panic, but it is also not a reason to assume the enthusiast content you find online reflects the clinical consensus, because there is not much clinical consensus yet to reflect.

• BPC-157 is derived from a human gastric protein but is synthesized in a lab, not produced endogenously in therapeutic amounts.
• Animal studies on tendon and gut healing are real, but human RCT data does not exist as of 2024.
• The FDA's 2023 guidance restricts BPC-157 from compounding, which affects how it can be legally prescribed through telehealth platforms.
• Injecting near an injury site is a common community practice, not a validated clinical protocol.